FDA Statement regarding azithromycin (Zithromax) and the risk of cardiovascular death – Center for Food Safety and Applied Nutrition

Azithromycin was the only macrolide examined in the published study; the study did not address other macrolide antibacterial drugs, such as clarithromycin (Biaxin) and erythromycin, regarding the potential for cardiovascular death. In 2011, FDA reviewed …

Leave a Reply

Your email address will not be published. Required fields are marked *